Ahead of ASCO 2026, Illumina unveiled an early-access MRD research kit using whole-genome sequencing and DRAGEN analysis.

Researchers developed PRINCE, a small-molecule-controlled CRISPR system enabling precise, long-term regulation of gene editing.

Bonito and DaltonTx aim to create an iterative learning loop for discovery of precision delivery systems for conjugated oligotherapeutics.

The data showed elevated levels of the metabolite αKG improved DNA repair, and blocking it made the cancer cells more sensitive to treatment.

The latest update to the ESM protein language model series supports binder design and protein function mapping for therapeutic discovery.

Researchers suggest MutationProjector offers a unifying framework for connecting tumor genotypes to biological mechanisms and therapeutic outcomes.

Eli Lilly has agreed to acquire three privately-held developers of vaccines for infectious diseases for a combined up-to-$3.83 billion cash, in deals intended to expand the acquisitive pharma giant’s ...

By developing their own functional nerves, these organoids demonstrate how engineering principles can drive biological ...

Parabilis Medicines, the developer of drugs and antibody-drug conjugates targeting historically undruggable protein targets ...

Biotech companies that use CDD Vault will be able to utilize select Lilly predictive models within their natural scientific ...

Regeneron Pharmaceuticals will partner with Parabilis Medicines to discover and develop an initial five candidates ...

Researchers say epigenetic phase variation mechanism may explain microbiome resilience and variability and could guide the ...